Literature DB >> 17628746

Primary diffuse leptomeningeal gliosarcomatosis.

Yosuke Watanabe1, Takuhiro Hotta, Hiroyuki Yoshioka, Yoko Itou, Kiyomi Taniyama, Kazuhiko Sugiyama.   

Abstract

We report a 48-year-old woman with primary diffuse leptomeningeal gliomatosis (PDLG) histologically diagnosed as gliosarcoma. She was admitted complaining of headache, numbness of the right arm, double vision, and visual field defects. Computerized tomography (CT) scans showed ventricular dilatation consistent with communicating hydrocephalus. Magnetic resonance imaging (MRI) revealed diffuse meningeal thickening and gadolinium enhancement without a definite intraparenchymal lesion. Whole-spine MRI demonstrated across-the-board dural thickening and gadolinium enhancement. Cytological examination showed atypical anaplastic cells. As no diagnosis could be made she underwent biopsy of the leptomeninges. Histological examination of the specimen returned a diagnosis of gliosarcoma. Despite chemotherapy and radiotherapy she died 11 months after admission. Autopsy findings included gliosarcoma in the leptomeninges and spinal cord without an underlying parenchymal tumor. To our knowledge, this is the first report of primary diffuse leptomeningeal gliosarcomatosis.

Entities:  

Mesh:

Year:  2007        PMID: 17628746     DOI: 10.1007/s11060-007-9459-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.506


  14 in total

1.  Sarcoma arising in glioblastoma of the brain.

Authors:  I H FEIGIN; S W GROSS
Journal:  Am J Pathol       Date:  1955 Jul-Aug       Impact factor: 4.307

2.  The endothelial hyperplasia of the cerebral blood vessels with brain tumors, and its sarcomatous transformation.

Authors:  I FEIGIN; L B ALLEN; L LIPKIN; S W GROSS
Journal:  Cancer       Date:  1958 Mar-Apr       Impact factor: 6.860

3.  Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosis.

Authors:  Enrico Franceschi; Giovanna Cavallo; Luciano Scopece; Roberta Degli Esposti; Gabriele Paioli; Anna Paioli; Emanuela Palmerini; Maria Pia Foschini; Anna Federica Marliani; Lucio Crinò
Journal:  J Neurooncol       Date:  2005-07       Impact factor: 4.130

4.  Heterotopic glial nests in the subarachnoid space; histopathologic characteristics, mode of origin and relation to meningeal gliomas.

Authors:  I S COOPER; J W KERNOHAN
Journal:  J Neuropathol Exp Neurol       Date:  1951-01       Impact factor: 3.685

5.  Primary diffuse leptomeningeal gliomatosis.

Authors:  P Bailey; Y Robitaille
Journal:  Can J Neurol Sci       Date:  1985-08       Impact factor: 2.104

6.  Gliosarcomas: analysis of 11 cases do two subtypes exist?

Authors:  Maurizio Salvati; Emanuela Caroli; Antonino Raco; Felice Giangaspero; Roberto Delfini; Luigi Ferrante
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

7.  Mixed glioblastoma multiforme and sarcoma. A clinicopathologic study of 26 radiation therapy oncology group cases.

Authors:  J M Meis; K L Martz; J S Nelson
Journal:  Cancer       Date:  1991-05-01       Impact factor: 6.860

8.  Smooth muscle can comprise the sarcomatous component of gliosarcomas.

Authors:  S F Haddad; S A Moore; R L Schelper; J A Goeken
Journal:  J Neuropathol Exp Neurol       Date:  1992-09       Impact factor: 3.685

Review 9.  Primary diffuse leptomeningeal gliomatosis (PDLG): a neoplastic cause of chronic meningitis.

Authors:  P Y Dietrich; M S Aapro; A Rieder; G P Pizzolato
Journal:  J Neurooncol       Date:  1993-03       Impact factor: 4.130

Review 10.  Primary diffuse multinodular leptomeningeal gliomatosis: case report and review of the literature.

Authors:  Bertrand Debono; Stéphane Derrey; Charles Rabehenoina; François Proust; Pierre Freger; Annie Laquerrière
Journal:  Surg Neurol       Date:  2006-03
View more
  1 in total

1.  Primary diffuse leptomeningeal gliosarcomatosis.

Authors:  Ju Hyung Moon; Se Hoon Kim; Eui Hyun Kim; Seok-Gu Kang; Jong Hee Chang
Journal:  Brain Tumor Res Treat       Date:  2015-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.